...
首页> 外文期刊>Journal of chemotherapy >Antibacterial resistance in Streptococcus pneumoniae and Haemophilus influenzae from Italy and Spain: data from the PROTEKT surveillance study, 1999-2000.
【24h】

Antibacterial resistance in Streptococcus pneumoniae and Haemophilus influenzae from Italy and Spain: data from the PROTEKT surveillance study, 1999-2000.

机译:来自意大利和西班牙的肺炎链球菌和流感嗜血杆菌的抗菌药耐药性:PROTEKT监测研究的数据,1999-2000年。

获取原文
获取原文并翻译 | 示例
           

摘要

Antibacterial resistance was evaluated among Streptococcus pneumoniae (n=252) and Haemophilus influenzae (n=202) from two centres in Spain (Barcelona and Madrid) and two centres in Italy (Genoa and Catania) collected during 1999-2000 as part of the ongoing PROTEKT (Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin) international surveillance program. Pneumococcal nonsusceptibility to penicillin G was found to be considerably higher in Spain (53.4%) than in Italy (15.1%), whereas erythromycin A resistance was higher in Italy (42.9%) than in Spain (28.6%). Among macrolide-resistant isolates investigated for resistance genes, the prevalence of mefA was higher among isolates from Italy (20/51, 39.2%) than among Spanish isolates (2/38, 5.3%). All other macrolide-resistant isolates possessed ermB. Telithromycin possessed good anti-pneumococcal activity against isolates from both countries (MIC90 0.03 mg/L [Spain]; 0.25 mg/L [Italy]), irrespective of resistance to other antibacterials. Beta-lactamase production among H. influenzae was low: Spain, 10.9%; Italy, 1.8%. With the exception of ampicillin and co-trimoxazole, all H. influenzae isolates were highly susceptible to the antibacterials tested, and all were inhibited by telithromycin at a concentration of < or = 2 mg/L. The findings of PROTEKT 1999-2000 highlight the importance of local resistance patterns in guiding the choice of empirical antibacterials for community-acquired respiratory tract infections.
机译:1999-2000年期间,在西班牙(巴塞罗那和马德里)的两个中心和意大利的两个中心(热那亚和卡塔尼亚)对肺炎链球菌(n = 252)和流感嗜血杆菌(n = 202)和意大利的两个中心(热那亚和卡塔尼亚)进行了耐药性评估。国际监测计划(PROTEKT(酮咯酸Telithromycin的预期耐药菌追踪和流行病学))。西班牙的肺炎球菌对青霉素G的不敏感性(53.4%)大大高于意大利(15.1%),而意大利的红霉素A耐药性高于西班牙(28.6%)(42.9%)。在研究抗药性基因的大环内酯类耐药菌株中,来自意大利的菌株(20/51,39.2%)中的mefA患病率高于西班牙菌株中的(2 / 38,5.3%)。所有其他对大环内酯类耐药的菌株均具有ermB。 Telithromycin对来自两个国家的分离株均具有良好的抗肺炎球菌活性(MIC90 0.03 mg / L [西班牙]; 0.25 mg / L [意大利]),无论对其他抗菌素的耐药性如何。流感嗜血杆菌中的β-内酰胺酶产量较低:西班牙为10.9%;意大利,占1.8%。除氨苄西林和复方新诺明外,所有流感嗜血杆菌分离株均对所测试的抗菌药物高度敏感,并且全部浓度≤2 mg / L的泰利霉素均对其抑制。 PROTEKT 1999-2000的发现强调了局部耐药模式在指导社区获得性呼吸道感染的经验性抗菌药物选择方面的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号